maxolon 10 mg tablets
amdipharm limited - metoclopramide hydrochloride - tablet - 10 milligram(s) - propulsives; metoclopramide
maxolon 5 mg/ml solution for injection
amdipharm limited - metoclopramide hydrochloride - solution for injection - 5 milligram(s)/millilitre - propulsives; metoclopramide
metoclopramide 5mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - metoclopramide hydrochloride - solution for injection - 5 milligram(s)/millilitre - propulsives; metoclopramide
motilium suspension 1 mgml
johnson & johnson international (singapore) pte ltd - domperidone - suspension - 1 mg/ml - domperidone 1 mg/ml
motilium tablet 10 mg
johnson & johnson pte. ltd. - domperidone - tablet, film coated - 10 mg - domperidone 10 mg
metoclopramide s.a.l.f 10 mg2 ml
raz pharmaceutics ltd, israel - metoclopramide hydrochloride - solution for injection - metoclopramide hydrochloride 5 mg/ml - metoclopramide - metoclopramide s.a.l.f 10 mg/2 ml is indicated in adults for: - prevention of postoperative nausea and vomiting (ponv) - prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv) - prevention of nausea and vomiting caused by radiation therapy - symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. in migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. - diabetic gastroparesis - to faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) pediatric population. metoclopramide s.a.l.f 10 mg/2 ml is indicated in children aged 1 to 18 years for: - second line-therapy: treatment of established postoperative nausea and vomiting (ponv) - second-line therapy: prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv) - to facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations).
ibuprofen tablet, film coated
bryant ranch prepack - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reac
domerid 10mg tablets
rowex ltd - domperidone - tablet - 10 milligram(s) - propulsives; domperidone
domerid relief 10mg tablets
rowex ltd - domperidone - tablet - 10 milligram(s) - propulsives; domperidone
motilium 1mg/ml oral suspension
mcneil healthcare (ireland) ltd - domperidone - oral suspension - 1 milligram(s)/millilitre - propulsives; domperidone